<DOC>
	<DOCNO>NCT03007615</DOCNO>
	<brief_summary>To evaluate safety investigational product verification sign irritability sensitization genital mucosa , well instrumental moisturize efficacy TEWL barrier integrity analysis , addition efficacy perceive volunteer .</brief_summary>
	<brief_title>Dermal Gynecological Acceptability ( Irritability Sensitization Genital Mucosa ) Investigational Product Evaluation Moisture Efficacy TEWL Perceived Efficacy .</brief_title>
	<detailed_description />
	<criteria>Healthy female sex active sex life ; Age group : 45 65 year old ; Menopause least six month ; Whole skin region product analysis ; No history reaction product category Understanding , agreement signature Term Free Informed Consent . Gestation risk gestation ; Use antiinflammatory / immunosuppressive drug ( last 30 day study ) ; Active cutaneous pathology ( local / disseminate ) evaluation area ; Pathologies cause suppression immunity , diabetes , HIV , etc . ; Endocrine pathologies thyroid disorder , ovarian adrenal gland disorder ; Any infection region analysis product diagnose time inclusion ; Other condition consider investigate physician reasonable disqualification individual study participation .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>